北京诺华制药有限公司

About Beijing Novartis Pharma
Beijing Novartis Pharma Ltd develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, infectious diseases, pain & osteoporosis, organ transplantation, central nervous system, and opthalmics areas. BNP has been awarded as Best Employer and Most Socially Responsible Company in China.

Novartis originated from Latin “novae artes”, meaning “new skills”. The Chinese name “nuo hua” means commitment to China, commitment to improving the health and living quality of the Chinese people with innovative products and services. Established in 1987 and headquartered in Beijing, BNP is an affiliate of Novartis AG.

About Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies. In 2010, the Group’s continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates (including 16,700 Alcon associates) and operate in more than 140 countries around the world. With significant strategic investments in an integrated research and development center located in Shanghai, a pharmaceutical production site located in Changping, Beijing and a patented drug substance production site located in Changshu, Jiangsu, Novartis aims for long-term development in China. For more information, please visit ww***com[点击查看] and ww***.cn[点击查看].

关于北京诺华制药有限公司
北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经、以及眼科。北京诺华制药曾获得“最佳雇主”和“最负社会责任的企业”等殊荣。
诺华源于拉丁文novae artes，意为“新技术”。公司的中文名字——诺华，取意承诺中华，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华集团。
诺华集团为患者和社会提供医药保健解决方案，以满足其日益变化的需求。2010年，集团持续经营业务实现了净销售506亿美元。集团研发投入约为91亿美元（除去减值及摊销费用为81亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有119,000位全职员工（包括16,700爱尔康员工）。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站ww***com[点击查看]和ww***.cn[点击查看]。